Literature DB >> 105076

Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes.

T Yoneda, G R Mundy.   

Abstract

The production of osteoclast-activating factor (OAF) by normal human peripheral blood leukocytes stimulated by phytohemagglutinin was inhibited by a series of structurally unrelated inhibitors of prostaglandin synthetase. Inhibition of OAF production by these agents was reversed by adding prostaglandins of the E series back to the leukocyte suspension. These results indicate that prostaglandin synthesis is necessary for OAF production.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 105076      PMCID: PMC2184753          DOI: 10.1084/jem.149.1.279

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Release of osteoclast activating factor by normal human peripheral blood leukocytes.

Authors:  C L Trummel; G R Mundy; L G Raisz
Journal:  J Lab Clin Med       Date:  1975-06

2.  BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.

Authors:  L G RAISZ
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

3.  Prevention of MIF activity by agents known to increase cellular cyclic AMP.

Authors:  W J Koopman; M H Gillis; J R David
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

4.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

5.  Macrophage-lymphocyte synergy in the production of osteoclast activating factor.

Authors:  J E Horton; J J Oppenheim; S E Mergenhagen; L G Raisz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

7.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

8.  The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.

Authors:  R Lomnitzer; A R Rabson; H J Koornhof
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

9.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  20 in total

1.  Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.

Authors:  E Moilanen
Journal:  Agents Actions       Date:  1989-03

2.  Case report 402: Megakaryocytic myelosis with disseminated osteolysis and osteomyelosclerosis.

Authors:  A Herrera; D Urbanitz; A Rossner; G Lingg; E Grundmann
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

3.  Influence of pharmacological doses of calcitonin on serum beta 2 microglobulin concentration.

Authors:  H Mulder; H van Bolhuis; M A Naafs; P L Winckers
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

4.  Production of the lymphokine, macrophage aggregating factor, is not inhibited by histamine.

Authors:  P Badenoch-Jones
Journal:  Experientia       Date:  1982-10-15

5.  Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.

Authors:  L Rifas; V Shen; K Mitchell; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Differences in prostanoid production between healthy and rheumatic synovia in vitro.

Authors:  E Moilanen; E Seppälä; M Nissilä; H Vapaatalo
Journal:  Agents Actions       Date:  1987-02

Review 7.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse.

Authors:  M Horowitz; A Vignery; R K Gershon; R Baron
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.

Authors:  T Yoneda; G R Mundy
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

10.  Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM).

Authors:  J D Geratz; R R Tidwell; J H Schwab; S K Anderle; K B Pryzwansky
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.